Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02521493
Title Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Children's Oncology Group
Indications

acute myeloid leukemia

Therapies

Etoposide

Thioguanine

Cytarabine

Asparaginase Erwinia chrysanthemi

mitoxantrone hydrochloride

Daunorubicin

Asparaginase

Age Groups: child
Covered Countries USA | CAN


No variant requirements are available.